Automated Email Reminder Changes: Weekly to Bi-Weekly & New Monthly Email

As you know, OMNI sends out periodic automated emails to provide up-to-date information to all CSBs/agencies about current intake and follow-up GPRA statuses. These are automatically emailed when (1) intakes have not been completed for an extended period (over 30 days) or (2) when follow-up windows are open or closing within the next two weeks. Only CSBs/agencies needing these reminders will receive them. These emails serve as an additional resource (in tandem with tracking sheets) for CSBs/agencies to keep track of their overall GPRA workflow.

Starting in December, there will be two changes to these emails:

  1. OMNI will be changing the frequency of these email updates from weekly to bi-weekly (every other week).

  2. A helpful new automated monthly email will arrive to notify you only if your CSB/agency has recorded duplicate interview follow-up or discharge GPRA surveys in the online system. This email is another TA tool to help keep your GPRA data accurate, and we hope you’ll find it useful!

We are happy to report that overall, the total number of GRPA issues has been decreasing as a result of our recent TA with you and your teams! We sincerely appreciate your efforts in collaborating with OMNI to address GPRA issues in a timely way, if and when they arise. We thank you for your dedication to maintaining accurate GPRA data!

As always, please don’t hesitate to reach out to OMNI with any questions or concerns at SORSupport@omni.org.

https://www.ecfr.gov/current/title-2/subtitle-A/chapter-II/part-200#200.112 Per 2 C.F.R. § 200.112-1113 The Federal awarding agency must establish conflict of interest policies for Federal awards. The non-Federal entity must disclose in writing any potential conflict of interest to the Federal awarding agency or pass-through entity in accordance with applicable Federal awarding agency policy. Failure to adhere to these statues will result in immediate termination of funding.

Virginia’s State Opioid Response (SOR) grant is awarded at the discretion of DBHDS and SAMHSA. All recipients of SOR funding supports evidence-based prevention, treatment and recovery services to address opioid and stimulant misuse and use disorders, including for cocaine and methamphetamine. The SOR grant is not intended to be utilized as a long-term or permanent funding source. All SOR proposals must include a realistic plan for financial sustainability beyond the grant period.